Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Arena Pharmaceuticals Inc. ARNA

Healthcare Biotechnology
Arena Pharmaceuticals is a biotechnology company targeting G-protein-coupled receptors. The company has one internally discovered drug, lorcaserin, which has been approved and is marketed in the U.S. and South Korea to target weight management. It is commercialized under the brand name Belviq. The company is collaborating with Eisai to market Belviq in other countries. It has a presence in... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ARNA)

No current news is available.
View More News ››

Opinion & Analysis (NDAQ:ARNA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ARNA)

5 PROMISING STOCKS IN ALOPECIA AREATA

5 PROMISING STOCKS IN ALOPECIA AREATA   1 In 5 Americans Are Losing Their Hair... More than 50 percent of women experience...
AviseAnalytics - July 7, 2021

Nice .... approval!

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) revealed Monday that the United States Adopted Names (USAN) Council has approved...
Interpolation1 - June 13, 2016

geez .... last post is from 2013. Nice pop today in SP

no news though ....
Interpolation1 - May 27, 2016

RE:Arena (ARNA) is a Winner For Investors

ARNA After Hours session closed @ 4.60, up another +1.21% on top of today's +2.36%. Added today to bring position up to 92...
MiamiGent - October 24, 2013

Arena (ARNA) is a Winner For Investors

Arena (ARNA) is a Winner For Investors Arena (ARNA) is a winner for investors ...and currently at a very attractive...
MiamiGent - October 24, 2013

Wells-Fargo-Healthcare-Conference Updates

Talks about BELVIQ in general and also about their pipeline. [url=http://www.earningsimpact.com/Transcript/81730/ARNA/Arena...
EarningsImpact1 - July 18, 2013
View more Bullboard ››

Mirasol Resources Ltd.

Mirasol Resources Ltd.

Mirasol Resources Ltd. is a Canada-based mineral exploration company focused on quality copper, gold and silver discoveries ...
View More »